Ritonavir
REF : BP1210
Descrição :Ritonavir British Pharmacopoeia (BP) Reference Standard
Clique para mais informações
Clique para mais informações
Categoria : Selected Certified Reference Materials
Descrição detalhada : Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles., This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Sinónimos : 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Fórmula molecula r: C37H48N6O5S2
Armazenamento : 2-8C
Embalagem : 1X1EA
Sinónimos : 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Fórmula molecula r: C37H48N6O5S2
Armazenamento : 2-8C
Embalagem : 1X1EA
